Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi

Since 2013, HITAP has supported HTA development and capacity building in the Philippines. In 2019, the Philippines mandated the provision of universal health coverage to all Filipinos. To support the decision-making for this promising undertaking, the partners continue their collaboration through technical assisatance on national HTA guidelines, on

During this period of rapid change and transition with the COVID-19 pandemic, the use of evidence is increasingly important. A webinar series and corresponding toolkit can support country partners and researchers to continue growing in knowledge and understanding in this field despite the restrictions on travel and face-to-face support. The webinar

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.

Building technical capacity as well as providing technical support to conduct HTA related study and institutionalise HTA process in Bhutan.

Providing technical support on HTA studies and support with capacity building through knowledge exchange.

Providing technical support to the UHC agency in Senegal to institutionalise HTA.

Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The